The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?

by Chalabreysse, L., Chan, J.K.C, Dacic, S., Detterbeck, F., French, C.A, Hornick, J.L, Inagaki, H., Jain, D., Lazar, A.J, Marino, M., Marom, E.M, Marx, A., Moreira, A.L, Nicholson, A.G, Noguchi, M., Nonaka, D., Papotti, M.G, Porubsky, S., Rajan, A., Roden, A.C, Sholl, L.M, Ströbel, P., Tateyama, H., Thomas de Montpréville, V., Travis, W.D
Published 2022

High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma

by Li, F., Li, S., Lv, C., Yang, Q.-K, Zhang, Y.
Published 2021

LINC00511 enhances LUAD malignancy by upregulating GCNT3 via miR-195-5p

by Hu, X., Xiao, P., Zhang, Y.
Published 2022

Non-small-cell lung cancer classification via RNA-Seq and histology imaging probability fusion

by Carrillo-Perez, F., Castillo-Secilla, D., Guillén, A., Herrera, L.J, Molina-Castro, Y., Morales, J.C, Rojas, I.
Published 2021

Cluster analysis evaluating PM2.5, occupation risk and mode of transportation as surrogates for air-pollution and the impact on lung cancer diagnosis and 1-year mortality

by Hamid, F.A, Hassan, A., Hassan, T., Jeyabalan, T., Latif, M.T, Soo, C.I, Vadiveel, Y., Wahab, S.A, Yu-lin, A.B
Published 2019

N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment

by Guo, M., Li, Z., Ming, L., Qin, Z., Wan, J., Wang, Y., Yang, Z., Zhao, Z., Zheng, J.
Published 2021

Guanylate-binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients

by Gao, F., Li, L., Qu, J., Wan, Q.
Published 2021

Aberrant expression of HIF3A in plasma of patients with non-small cell lung cancer and its clinical significance

by Chen, Y., Gong, P., Wei, L., Yuan, N.
Published 2021

miR-423-3p activates FAK signaling pathway to drive EMT process and tumor growth in lung adenocarcinoma through targeting CYBRD1

by Bai, X., Feng, Y., Huang, W., Ma, J., Qi, Q., Sun, X., Wang, C., Zhang, L., Zhang, Q., Zhu, C.
Published 2021

Dysregulated ferroptosis-related genes indicate potential clinical benefits for anti–PD-1/PD-L1 immunotherapy in lung adenocarcinoma

by Chen, Y., Li, T., Zhang, X., Zhou, M.
Published 2021

Deep Learning Methods for Lung Cancer Segmentation in Whole-Slide Histopathology Images - The ACDC@LungHP Challenge 2019

by Chen, H., Chen, Y.-C, Hong, Y., Jiang, Y., Jung, H., Khanagha, V., Ko, J., Lee, B., Li, D., Li, N., Li, Y., Li, Z., Litjens, G., Liu, L., Liu, Y., Liu, Z., Maevskikh, P., Schuffler, P.J, Sun, S., Sun, X., Tan, T., Tang, Y., Teng, X., Wang, C.-W, Xiao, Y., Yan, J., Yu, L., Yu, Q., Yurovskiy, V., Zhang, J., Zhang, Q., Zhao, H., Zheng, Y.
Published 2021

Development of risk prediction models for lung cancer based on tumor markers and radiological signs

by Bi, X., Chen, T., Lu, Y., Tu, Y., Wu, Y.
Published 2021

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

by Bachier, C., Bai, J., Batrakou, D., Blumenschein, G.R, Broad, R., Devarakonda, S., Doger de Spéville, B., Edelman, M.J, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gainor, J., Gerry, A., Govindan, R., Heymach, J.V, Holdich, T., Hyland, N., Johnson, M., Lam, V.K, Marks, D., Moreno, V., Navenot, J.-M, Norry, E., Olszanski, A.J, Pentony, M.M, Sanderson, J.P, Wolchinsky, Z.
Published 2022